Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
Authors:
Open Access
- 21 November 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (64) , 107666-107677
Abstract
Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancerKeywords
This publication has 29 references indexed in Scilit:
- YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivoOncotarget, 2016
- Yes associated protein is a poor prognostic factor in well-differentiated lung adenocarcinoma.2015
- Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer PatientsClinical Cancer Research, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Cancer treatment and survivorship statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer PatientsPLOS ONE, 2014
- Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates with Poor PrognosisClinical Cancer Research, 2011
- Yap1 Acts Downstream of α-Catenin to Control Epidermal ProliferationCell, 2011
- TEAD mediates YAP-dependent gene induction and growth controlGenes & Development, 2008
- TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteinsThe EMBO Journal, 2000